ME
TNDM icon

McIlrath & Eck’s Tandem Diabetes Care TNDM Stock Holding History

McIlrath & Eck’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8K Hold
1,605
– – ﹤0.01% 692
2025
Q4 		$35.3K Hold
1,605
– – ﹤0.01% 410
2025
Q3 		$19.5K Hold
1,605
– – ﹤0.01% 509
2025
Q2 		$29.9K Buy
1,605
+390
+32% +$7.72K ﹤0.01% 405
2025
Q1 		$23.3K Hold
1,215
– – ﹤0.01% 455
2024
Q4 		$43.8K Hold
1,215
– – 0.01% 345
2024
Q3 		$51.5K Buy
+1,215
New +$51.5K 0.01% 301

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

McIlrath & Eck's TNDM Position: Q1 2026 in Review

McIlrath & Eck held its Tandem Diabetes Care (TNDM) position steady in Q1 2026 at 1,605 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

McIlrath & Eck first reported a position in TNDM in Q3 2024 and has held it in 7 quarters since. The position peaked at $51.5K in Q3 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • McIlrath & Eck held 1,605 shares of Tandem Diabetes Care worth $30.8K as of Q1 2026.
  • McIlrath & Eck left its Tandem Diabetes Care share count unchanged in Q1 2026.
  • Tandem Diabetes Care made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #692 holding.
  • McIlrath & Eck first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 7 quarters since.
  • McIlrath & Eck's Tandem Diabetes Care position peaked at $51.5K in Q3 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.